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With millions of DNA bases encountering more than 10,000oxidative lesions per day,1 DNA repair proteins are charged
with the daunting task of searching an entire genome to detect and
repair these multiple sites of damage.2,3 Our laboratory has proposed
that DNA repair proteins search for DNA lesions by exploiting
DNA/protein charge transport (CT). DNA CT occurs over long
molecular distances but is remarkably sensitive to DNA lesions.46
Endonuclease III (EndoIII) andMutY are base excision repair (BER)
proteins inEscherichia coli that contain [4Fe-4S] clusters which, when
bound to DNA, are activated toward one-electron oxidation.7,8
EndoIII and MutY homologues are found in many species, ranging
from bacteria to humans, and their structural biology and enzymatic
properties have been studied in great detail by both crystallo-
graphy914 and mutagenesis-based enzymology.7,13,1522 Both en-
zymes are present in low copy number in vivo (∼30 copies per cell of
MutY and∼500 copies per cell of EndoIII),3 making their ability to
find and repair DNA lesions all the more remarkable. MutY has also
drawn attention from the biomedical community because patients
with mutations in its human homologue, MUTYH, are predisposed
toward developing colorectal cancer.2327
Despite these extensive studies, two features of the BER family
of enzymes remain intriguing to consider. First, what is the role of the
[4Fe-4S] cluster? The [4Fe-4S] cluster does not participate in base
excision in either enzyme, nor is it necessary for MutY to fold
properly,7 although it is essential for MutY to bind DNA. Second,
how are these proteins able to scan the vast amount of DNA present
in a cell in order to detect their substrate lesions? Although the
excision step in repair by these BER glycosylases has been well
characterized, the answer to these questions has not been resolved.
Our laboratory has proposed a model in which MutY and
EndoIII cooperatively scan the genome for DNA lesions using their
[4Fe-4S] clusters to participate in DNA-mediated redox signal-
ing.2831 DNAmediates CT very efficiently owing to the π-stacking
of the aromatic, heterocyclic base pairs within the helix.5,32,33 CT
throughproteins occurs through a variety ofmechanisms.3439These
CT mechanisms could permit charge to travel from the DNA into a
bound protein and then through the protein to a redox-active
cofactor, such as a [4Fe-4S] cluster. In this model, under oxidative
stress, oxidation of some DNA-bound protein occurs by a nearby
guanine radical, taking the [4Fe-4S] cluster from the 2þ form to 3þ.
DNA-mediated CT to another distally DNA-bound protein would
lead to its reduction and dissociation. This CT process relies on
proper π-stacking of the bases between the donor protein and the
distal acceptor protein, however;28 if the π-stack is perturbed by a
lesion, DNA-mediated CT will not proceed. Thus, this signaling
serves as a scan for the integrity of the intervening DNA as the first
step in damage detection, promoting the dissociation of repair
proteins away from unmodified DNA and leading to their relocaliza-
tion in the vicinity of damage (Figure 1).
One question that remains is how charge is transported from
theDNA, through the protein, to the [4Fe-4S] cluster ofMutY or
EndoIII. Specifically, which amino acids in these proteins facil-
itate CT between the DNA helix and the protein metal cluster?
One EndoIII mutant, Y82A, has already been shown to be
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ABSTRACT: Endonuclease III (EndoIII) is a base excision
repair glycosylase that targets damaged pyrimidines and con-
tains a [4Fe-4S] cluster. We have proposed a model where BER
proteins that contain redox-active [4Fe-4S] clusters utilize
DNA charge transport (CT) as a first step in the detection of
DNA lesions. Here, several mutants of EndoIII were prepared
to probe their efficiency of DNA/protein charge transport.
Cyclic voltammetry experiments on DNA-modified electrodes show that aromatic residues F30, Y55, Y75, and Y82 help mediate
charge transport between DNA and the [4Fe-4S] cluster. On the basis of circular dichroism studies to measure protein stability,
mutations at residues W178 and Y185 are found to destabilize the protein; these residues may function to protect the [4Fe-4S]
cluster. Atomic force microscopy studies furthermore reveal a correlation in the ability of mutants to carry out protein/DNACT and
their ability to relocalize onto DNA strands containing a single base mismatch; EndoIII mutants that are defective in carrying out
DNA/protein CT do not redistribute onto mismatch-containing strands, consistent with our model. These results demonstrate a
link between the ability of the repair protein to carry out DNACT and its ability to relocalize near lesions, thus pointing to DNACT
as a key first step in the detection of base damage in the genome.
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deficient in CT activity, implicating Y82 as a crucial residue in the
CT pathway of EndoIII.28 The current study builds on this result
by characterizing several novel mutants of EndoIII to discover other
residues that mediate protein/DNA CT. Several categories of
mutants were prepared, including five additional mutants at or near
the Y82 position, to better assess the types of amino acid side chains
that areCTproficient inEndoIII.Mutationswere alsomade targeting
other aromatic residues in the protein because aromatic amino acids
have been shown to mediate CT in other systems.3539 A third
category ofmutationsweremadenear the [4Fe-4S] cluster, assuming
that amino acids close to this redox-active moiety would likely lie
along theCTpathway. All of themutantswere characterized by cyclic
voltammetry on DNA-modified electrodes, glycosylase assays, and
some by circular dichroism (CD) spectroscopy. These experiments
helped us identify several amino acids that facilitate CT between the
DNA helix and the [4Fe-4S] cluster.
Upon characterization of EndoIII mutants, we then applied
them in atomic forcemicroscopy (AFM) studies to examine this first
step of lesion detection. AFM is a valuable technique that allows for
visualization of single-molecule protein/DNA interactions.4042
AFM requires very low concentrations of DNA and protein for
measurements and relies on cationic interactions for DNA/surface
contact rather than chemical modifications. AFM images can be used
to pinpoint the position of proteins onDNA and hence the statistical
distribution of proteins along the strand.43,44Here, thenAFMmay be
used to test our model of protein redistribution on DNA in the
vicinity of a lesion that interferes with CT. Indeed, we find a
correlation between the ability of mutants to carry out DNA/protein
CT and their ability to relocate near a single base mismatch.
’MATERIALS AND METHODS
Preparation of DNA and Protein Samples for Electro-
chemistry Experiments. Redmond Red (RR) is a redox-active
probe used to quantify the amount of DNA on the electrode
surface.45 The sequences used for electrochemistry experiments
were SH-(C6H12)-(RR)-50-GA GAT ATA AAG CAC GCA-30
and complement and SH-(C6H12)-50-AGT ACA GTC ATC
GCG-30 annealed to 50-CGC GAT GAC TGT ACT-30-RR.
Redmond Red was connected to the oligonucleotide via a pyrrolidi-
nyloxy linker. RedmondRed-labeledDNAwasprepared according to
established methods.4 Briefly, all DNA sequences were prepared
using standard phosphoramidite chemistry on anAppliedBiosystems
3400DNAsynthesizer. Phosphoramiditeswerepurchased fromGlen
Research. For thiolated strands, the 50 endwasmodifiedwith the thiol
modifier C6 SS phosphoramidite using standard protocols from
Glen Research, Inc. DNA modified with Redmond Red on the 30
terminus was prepared on EpochRedmondRedCPG columns from
Glen Research with ultramild phosphoramidites and reagents. DNA
modified with Redmond Red attached to the thiol was prepared with
Epoch Redmond Red phosphoramidite from Glen Research with
ultramild phosphoramidites and reagents.
Deprotection, purification, chemical modification of DNA,
annealing, and preparation of the DNA-modified Au electrode were
performed as described previously.6,4648 Au substrates were pur-
chased from Agilent Technologies. Each experiment used 50 μL of
50100 μM EndoIII in protein buffer (20 mM NaH2PO4 pH 7.5,
100 mMNaCl, 5% glycerol, 1 mM EDTA). The protein concentra-
tion was quantified using ε410 = 17,000 M
1 cm1.49
Cyclic Voltammetry. All cyclic voltammetry experiments
were performed as described previously.2830 A Au on mica
(Molecular Imaging) electrode was assembled and incubated
with thiol-modified DNA duplex for 2436 h in the absence of
Mg2þ; under these conditions, the DNA is loosely packed on the
surface and protein can diffuse through themonolayer. The electrode
was then backfilled with 1 mM mercaptohexanol, rinsed in DNA
buffer (50 mMNaCl, 5 mMNaH2PO4, pH 7.5), and then rinsed in
protein buffer before protein samples were added to the surface. The
DNA-modified Au electrode served as the working electrode, a Pt
wire served as the auxiliary electrode, and the reference was either
a Ag/AgCl electrode modified with an agarose tip or a 66-EE009
Ag/AgCl reference electrode (ESABiosciences). All scanswere taken
at a rate of 50mV/s on aCH Instruments 760 potentiostat. To begin
an experiment, a protein sample was placed on an electrode surface
and successive scanswere taken every 5min until the signal stabilized.
Protein concentrations used were those required to saturate binding
to the surface as determined by titration.29,30 It should be noted that
interfacial electron transfer rates redox of moieties bound toDNA on
these DNA-modified surfaces are limited by tunneling through the
alkanethiol linker based on measurements of peak widths as a
function of scan rate.4
To determine the relative CT efficiencies of EndoIII mutants,
the signal intensity of the proteins was normalized to DNA
concentration using the intensity of the Redmond Red signal and
compared one to another on the same surface. For each comparison,
the protein samples were measured consecutively on the same
electrode surface. Thus, to compare the CT signal strength of each
mutant relative toWT EndoIII, the peak under the reductive and/or
oxidative cyclic voltammogram curve (consistently for different
proteins on a given surface) was measured using the linear baseline
correctionofCH Instruments’ElectrochemicalWorkstation software
program. After each measurement of a protein sample, the electrode
surface was rinsed, and the measurement was repeated for the
Redmond Red signal. The intensity measured for each mutant was
divided by that of the Redmond Red signal measured on the rinsed
electrode immediately following the mutant scan. This ratio was also
tabulated for wild-type EndoIII on each electrode. The final ratios
reported are those of the Redmond Red corrected mutant value
Figure 1. Model for the first step in damage detection by BER proteins.
Given two repair proteins of similar potential (red and blue), CT can
proceed throughwell-matched unmodifiedDNA(top). Stimulated through
oxidation by guanine radicals (yellow) formed under oxidative stress, DNA
CT occurs between DNA-bound repair proteins, promoting the dissocia-
tion of reduced protein.DNACTdoes not occur (bottom), however, in the
presence of an intervening mismatch or lesion (red X); repair proteins are
not reduced, do not dissociate, and instead remain bound in the vicinity of
the lesion. On a slower time scale, the proteins can then processively move
to the lesion site for repair. This process leads to the redistribution of
proteins in the vicinity of the lesion.
6135 dx.doi.org/10.1021/bi2003179 |Biochemistry 2011, 50, 6133–6145
Biochemistry ARTICLE
divided by the Redmond Red corrected wild-type value. This
procedure provides a correction for the variability in surface coverage
associated with individual DNA-modified surfaces. Surface coverages
were typically 5 pmol/Å2, but variations of∼50% were apparent for
different electrodes on different days.
Preparation of EndoIII Overexpression Construct. The nth
gene that encodes EndoIII was cloned using the Failsafe Systemwith
Buffer G (Epicenter Biotechnologies) and plasmid pBBR1MCS-450
which contains the nth gene as a template. (This construct was
originally prepared by cloning the nth gene from Escherichia coli
chromosomalDNA.) Primers usedwere 50-CGCCCGCGGTGGT
ATG AAT AAA GCA AAA GCG CTG-30 and 50-CGC GGATCC
TCA GAT GTC AAC TTT CTC TTT-30. PCR products were
purified on a 1% agarose gel and then excised using the QIAquick gel
extraction kit (Qiagen). These fragments were ligated into the
BamHI and SacII sites of the pET11-ubiquitin-His vector, which
expresses hexahistidine and ubiquitin tags at the N-terminus of the
insertion site. This vector was derived from the pET11 vector
(Novagen), but the ubiquitin gene and hexahistidine tag were
engineered into the vector by the laboratory of S. Mayo, from whom
this vector was a kind donation. The ligation reaction was used to
transform both DH5R E. coli (Invitrogen) for subcloning and
BL21star(DE3)pLysS E. coli (Invitrogen) for overexpression. Trans-
formants resistant to ampicillin and chloramphenicol were selected,
and the plasmids were isolated using the QIAPrep MiniPrep kit
(Qiagen). After the size of the insert was verified by restriction
digestion, plasmids from positive transformants were submitted for
sequencing (Laragen). Freezer stocks of transformants containing
the correct EndoIII sequence were prepared and stored at 80 C.
Purification of EndoIII andMutants.WT EndoIII and Y82A
samples used for AFM experiments were prepared as described
previously.28 Protein samples for other experiments and all other
mutants were prepared as described here. Freezer stocks of BL21star-
(DE3)pLysS containing pET11-ubiquitin-Hiswith the nth genewere
used to inoculate 10 mL of LB media containing 100 μg/mL
ampicillin and 30 μg/mL chloramphenicol. Each 10 mL culture
was incubated at 37 C overnight and then used to inoculate 1 L
of LB/ampicillin/chloramphenicol. Each 1 L flask was grown to
OD600 = 0.6 at 37 C, and then isopropyl β-D-1-thiogalactopyrano-
side was added to a total concentration of 0.3 mM. Cells were
incubated at 30 C for 3.5 h and harvested by centrifugation
(5000 rpm, 10 min). Pellets were stored at80 C. For lysis, pellets
were dissolved in 25 mL of lysis buffer (50 mM Tris-HCl, pH 8, 5%
glycerol, 250 mM NaCl, 5 mM DTT, 1 mM phenylmethylsulfonyl
fluoride) and lysed by sonication. Cell lysate was fractionated by
centrifugation (7000 rpm, 10min). The supernatant was filtered and
then loaded onto a 5mLHisTrapHP column (GEHealthcare) pre-
equilibrated with binding buffer (20 mM sodium phosphate, 0.5 M
NaCl, 20 mM imidazole, 1 mM DTT, pH 7.4) at a flow rate
of∼1mL/min.The columnwaswashedwith binding buffer until the
UVbaselinewas stable.The fusionproteinwas elutedusing a gradient
of 0100% elution buffer (20 mM sodium phosphate, 0.5 M NaCl,
500 mM imidazole, 1 mM DTT, pH 7.4) over 1020 column
volumes on an AKTA FPLC (GE Healthcare). Fractions containing
protein (determined by their yellow color) were pooled and loaded
onto a Superose 12 column (GE Healthcare) that had been pre-
equilibrated with Superose 12 Buffer (50 mM NaH2PO4, 0.15 M
NaCl, pH 7.0). The tagged EndoIII, His6-ubiquitin- EndoIII, eluted
after ∼12 mL. Fractions containing EndoIII were pooled and
dialyzed overnight into protein storage buffer (20 mM sodium
phosphate pH 7.5, 0.5 mM EDTA, 100 mM NaCl, 20% glycerol).
Aliquots of 5070 μL EndoIII were prepared, frozen in dry ice, and
stored at 80 C. Protein purity was assessed by SDS-PAGE, and
concentration was measured using ε410 = 17 000 M
1 cm1.49
Site-Directed Mutagenesis.Mutations were encoded on the
pET-11 based EndoIII overexpression plasmid using the Quik-
change Site-DirectedMutagenesis Kit (Stratagene). Primers used are
listed in the Supporting Information, where uppercase letters indicate
the encoded mutation. DNA primers were purchased from Inte-
grated DNA Technologies. All mutagenized plasmids were se-
quenced (Laragen) to verify accurate mutagenesis before being
used for protein overexpression.
Instrumentation. All protein samples were examined using a
Beckman DU 7400 spectrophotometer. Protein concentration
was measured using ε410 = 17 000 M
1 cm1.49
Circular Dichroism. Samples were measured at a concentra-
tion of ∼5 μM at ambient temperature on a Model 62A DS
circular dichroism spectrometer (AVIV, Lakewood, NJ). For thermal
denaturation experiments, the temperature was varied from 20 to
60 C. Each trace shown is the average of at least three independent
experiments.
DNA Glycosylase Assay. This protocol was adapted from
methods described previously.15 DNA strands synthesized were
50-TGTCAATAGCAAGXGGAGAAGTCAATCGTGAGT
CT-30, where X = 5-hydroxyuracil, and the complement with G
opposite X. DNA was prepared using standard phosphoramidite
chemistry with reagents purchased from Glen Research. Prior to
annealing, single-strand DNA was purified using reversed-phased
HPLC, and the substrate-containing strandwas 50- radiolabeled using
32P-ATP51 with polynucleotide kinase purchased from Roche.
Glycosylase activity was determined by monitoring nick for-
mation in the hydroxyuracil-containing duplex using denaturing
gel electrophoresis.15 For this assay, 100 nM radiolabeled duplex
was incubated with EndoIII or a variant at a range of concentrations
(10 nM, 100 nM, or 1μM) in reaction buffer (10mMTris pH= 7.6,
1mMEDTA, 50mMNaCl) for 15min at 37 C.The reactionswere
quenched upon addition of NaOH to a final concentration of
100 nM. Samples were dried, counted by scintillation, and diluted
with loading buffer (80% formamide, 10 mMNaOH, 0.025% xylene
cyanol, 0.025% bromophenol blue in Tris-Borate-EDTA buffer) to
normalize the radioactivity. Samples were then heated at 90 C for
5 min prior to loading and then separated by denaturing PAGE.
Glycosylase activitywas determined by quantifying the amount of 14-
mer product visualized in the gel relative to the total amount of DNA
present.
Mismatched (C:A) Strand Synthesis. Four primers with the
following sequences were synthesized using standard phosphor-
amidite chemistry:
50-GTACAGAGTTCAGTCGGCATCCGCTTACAGACA-
AGC-30 (forward)
50-CCGGTAACTATCGTCTTGAGTCC-30 (reverse)
50-GACTGAACTCTGTACCTGGCACGACAGGTTTCC-
CG-30 (forward)
50-GACTGAACTCTATACCTGGCACGACAGGTTTCC-
CG-30 (forward)
The underlined bases highlight the location of a 20-O-methyl
residue (Glen Research). Primers were phosphorylated using 5U
PNK, 10% PNK buffer, 0.5 mM ATP for 5 h at 37 C. Primers
were purified using phenolchloroform extraction followed by
ethanol precipitation.52 After being dried in vacuo, primers were
redissolved in 20 μL of water and used in separate PCR
reactions53 using pUC19 as a template to generate two duplexes,
1610 bp and 2157 bp long and each containing one 14-nucleotide
single-strand overhang. Each 100 μL PCR reaction contained 50
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pmol of each of two primers, 1X Taq buffer (100 mM Tris-HCl,
15 mMMgCl2, 500 mM KCl, pH 8.3, 0.2 mM each dNTP, 1 ng
plasmid template pUC19 and 3 U Taq polymerase (Roche). A
typical step program for PCR was as follows: After incubation at
94 C for 10 min, 34 cycles were performed as follows: 94 C for
1 min, (52 C for primers 1þ 2, 54 C for primers 2þ 3 or 2þ
4), for 1 min, and 72 C for 3 min. The PCR product was then
suspended in 50 mM NaCl/5 mM phosphate buffer and
quantitated. Separate duplexes were annealed at 65 C for 8
min in 10mMTris buffer and then cooled to 20 C for 2 h. A total
of 15 units of T4DNA ligase (NewEngland Biolabs) and 10%T4
ligase buffer were added (total reaction volume ∼20 μL) and
incubated overnight at 16 C, followed by deactivation for 10min
at 65 C.We did not bring the ligation reaction to completion, so
as to obtain amixture of DNA samples that were equivalent other
than the presence of the mismatch at the ligation site. The DNA
duplexes (ligated, 3767 bp, and unligated, 1610 bp and 2157 bp)
were then analyzed by 0.6% agarose gel electrophoresis.
AFM Experiments. The protocol used was similar to that
reported previously.28 Briefly, mica surfaces were freshly cleaved
with tape. EndoIII (0.4 μM),28 stored in 20 mM phosphate,
20mMNaCl, 20% glycerol, 1 mMEDTA, was added to the stock
DNA solution containing 50100 ng of total DNA composed of
the mixture of ligated 3.8 kbp duplexes and the two unligated
duplexes (1.6 and 2.2 kb) in 6 mM MgCl2/Tris-EDTA buffer.
This protein/DNA solution was incubated at 4 C overnight and
deposited (510 μL) on the mica surface for 12min, rinsed with
2 mL of water, and dried under argon. Two of the five WT EndoIII
samples analyzed were deposited onto the mica surface in 5 ng
quantities, followed by immediate addition of 3.7μMEndoIII (1μL
volume). This difference in deposition conditions did not result in
any significant differences in the trends observed. Mutant protein
(Y82A) was added to a stock solution of 50 ng DNA for a final
protein concentration of 0.4μM.After incubation at 4 Covernight,
deposition conditions were identical to that for WT EndoIII- DNA
samples. For Y82F EndoIII, W178A EndoIII, or Y75A EndoIII
mutants (0.6 μM), stored in 20 mM sodium phosphate, pH 7.5,
100 mM NaCl, 20% glycerol, and 0.5 mM EDTA, protein/DNA
complexes were formed with DNA solution containing∼200 ng of
the mixture of ligated PCR product as well as the two nonligated
duplexes with overhangs (∼6 μM DNA) in 6 mM MgCl2/Tris-
EDTA buffer at 4 C overnight. The reaction mixture was then
deposited (510 μL) on the mica surface for 12min, rinsed with
2 mL of water, and dried under argon.
AFM Instrumentation. Silicon AFM Probes purchased from
Nanoscience Instruments (BudgetSensors), with a spring con-
stant of 3N/m and a resonance frequency of 75 kHz, were used in a
Digital Instruments Multimode SPM. Images were captured in air
with scan areas of 2 2 μm2 or 3 3 μm2 in tapping mode, at an
amplitude of 0.542.00 V, and at a scan rate of 3.05 Hz. Scan rates
of 3.05 Hz were used in order to obtain images of higher quality.
Binding Density Ratio Calculations. WSxM software was
used to measure general DNA contour lengths and height
profiles of the proteins as described previously.28,54 For each
data set, images from at least three independent samples were
analyzed, compared, and pooled (>200 long or short strands).
Distinguishable strands and proteins were counted by hand. The
binding density ratio, r, is defined as the ratio of the proteins
bound on long strands divided by proteins bound on short
strands. The ratio is normalized for length by dividing by 1.9 kbp,
which is the average length of the short strands. The uncertainty
was determined through the total number of proteins observed.
’RESULTS
Electrochemistry on DNA-Modified Electrodes. The CT
capabilities of several mutants of EndoIII were investigated on
DNA-modified electrode surfaces passivated with mercaptohex-
anol (Figure 2). This strategy has been used previously to
measure the DNA-bound electrochemical properties of proteins
containing [4Fe-4S] clusters.28,30 In this study, the thiolated
DNA duplex was also modified with Redmond Red, a redox
probe whose signal intensity can be used to measure the amount
of DNA on a given electrode surface.45 The Redmond Red was
positioned so that it could contact the Au surface and be directly
reduced without requiring DNA-mediated reaction.
For each EndoIII sample, the electrochemical signal grew in
over 3045 min. Scan rate dependence measurements on the
protein signal showed a linear relationship between the peak current
and the square root of scan rate, indicative of a diffusion-limited
process.55 These same experiments showed a linear relationship
between the peak current of Redmond Red and scan rate, indicative
of a surface-bound species. Thus, while themodifiedDNA is surface
bound, the protein freely diffuses to the DNA. Figure 2B,C shows
typical cyclic voltammograms of two separate surfaces, with two
peaks evident: one from the [4Fe-4S] cluster of the DNA-bound
protein and one from theRedmondRed probe.When compared on
these surfaces, all mutants exhibited midpoint potentials of 80( 30
mV vs NHE, and all were within error of that of WT (Table 1).
While the DNA-bound potential for these mutants was seen to be
invariant, significant variations in redox signal intensity were ob-
served (Table 1 and Figure 2D). The signal strength of eachmutant
was quantified and normalized to the amount of DNA covalently
bound on the electrode. To compare the signal strength of each
mutant relative to that ofWT, these signals were then normalized to
the Redmond Red-corrected signal strength of WT EndoIII mea-
sured on the same surface. This normalization accounts for the
variability in surface coverage associated with different electrodes.
Among the first samples to be examined weremutants relevant
to colorectal cancer research, those at positions L81 and Y82.
Y82F and Y82W exhibit signal strengths within error of that of
WT, suggesting that other aromatic residues at position 82 confer
CT capabilities equivalent to those of the native tyrosine. By con-
trast, Y82S exhibits a very weak electrochemical signal relative to
WT (Figure 2B,D). The signal intensity from Y82C is on average
the same as that of WT, although highly variable, possibly due to
the ability of cysteine to facilitate electron transfer in certain con-
texts,34,56,57 albeit through the formation of an unstable radical.
After the experiments with Y82 mutants established the impor-
tance of aromatic residues for DNA/protein CT, other aromatic
amino acids in EndoIII were targeted formutagenesis studies. F30A,
Y55A, Y75A, and H140A were examined. The first three of these
mutants all displayed a CT deficiency relative to WT EndoIII
(Figure 2D). In the protein structure, Y75, Y55, and F30 are
relatively close to Y82 and form a line along one side of the
protein.10,12,14 These residues may comprise a pathway of aromatic
amino acids through which electrons can travel efficiently. Such
aromatic “π-ways” have been found in other peptides.38,39 The
H140A mutant, by contrast, proved CT-proficient in the experi-
ments performed here so no conclusions can be made about its
electrochemical properties. However, this residue was found to be
enzymatically important (Table 2).
The final category of EndoIII mutants examined was W178A
and Y185A, substitutions involving aromatic residues close to the
[4Fe-4S] cluster. These mutants were expected to produce weak
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Figure 2. Quantitative cyclic voltammetry of EndoIII variants on DNA-modified electrodes. (A) Schematic of DNA-modified electrochemistry. A Au
surface is treated with thiol-modified DNA and then backfilled with mercaptohexanol. The covalent Redmond Red redox probe (red oval) is used to
quantify the amount of DNA on the surface. Each protein mutant was allowed to bind DNA on the surface, and the [4Fe-4S] cluster was measured by
cyclic voltammetry. The protein was then rinsed from surface and WT was measured on the same surface. (B) Representative cyclic voltammogram of
Y82S (brown) compared to WT EndoIII (blue). Y82S exhibits a weaker electrochemical signal. For reference, a scan taken in the absence of protein
(buffer only) is also shown (gray). (C) Representative cyclic voltammogram ofW178A (orange) compared toWTEndoIII (blue) and a buffer-only scan
(gray). (D) TheCT capability of eachmutant was quantified based on the area under its redox peak. Eachmutant’s signal intensity was normalized to the
intensity of the signal for WT measured on the same surface.
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electrochemical signals because of their proximity to the metal-
locluster, but they instead produced signals that were large and
highly variable relative to WT (Figure 2C,D). One explanation
for this phenomenon is protein aggregation, as denatured
samples can produce large and erratic signals on DNA-modified
electrodes (data not shown). However, because the midpoint
potentials of these mutants are within error of those produced by
other EndoIII samples, it is unlikely that the [4Fe-4S] cluster
degraded in W178A and Y185A, given that [3Fe-4S] clusters
have different potentials5860 than the [4Fe-4S] cluster. These
results with W178A and Y185A prompted further experiments,
described below, that suggest these residues may help protect the
[4Fe-4S] cluster from exposure to solvent.
Enzymatic Assays of Mutant Glycosylase Activity. The
glycosylase activity of each mutant was measured according
to established methods.15,28 Briefly, 35-mer strands of DNA
were synthesizedwith 5-hydroxyuracil (5-OH-dU), anEndoIII subs-
trate analogue, incorporated into the sequence. The sequence was
50-radiolabeled with 32P-ATP and annealed to its complement.
Solutions of 100 nM DNA were incubated with 1 μM enzyme.
Active enzymes will remove 5-OH-dU from the DNA backbone,
leaving an abasic site whose phosphodiester bonds are cleaved with 1
M NaOH. This cleavage produces a 14-mer strand, which can be
visualized by denaturing PAGE and autoradiography (Figure S1).
The amount of 14-mer relative to the total quantity ofDNAwas used
to assess enzymatic activity.Mutants that are glycolytically active bind
DNAcomparably toWT,whilemutants that bindDNApoorly show
diminished glycolytic activity.1517 Consequently, this experiment is
an important complement to the electrochemical studies, as it verifies
that any weak cyclic voltammetry signals produced by mutants stem
from a CT deficiency and not an inability to bind DNA.
Of the 11 mutants examined, most were found to exhibit
glycosylase activity within error of that of WT EndoIII (Table 2).
The exceptions were F30A andH140A. F30A was slightly impaired
in its glycolytic activity, possibly because F30 is located near the
substrate binding pocket of EndoIII,10,12,14 so mutations at this
position may impede DNA binding. H140A is deficient in glycosy-
lase activity relative to WT. In earlier crystallographic studies, the
H140 residue was identified as possibly increasing DNA binding by
providing a positively charged histidine.12 The enzymatic activity
results presented here are consistent with that hypothesis.
Circular Dichroism To Examine the Structural Stability of
EndoIII Mutants. While most of the mutants examined gave
electrochemical signals with intensities weaker than or within error of
those of WT EndoIII, the mutants W178A and Y185A were excep-
tions to this trend. Consequently, CD experiments were performed
to examine the secondary structure of W178A and Y185A. The CD
spectra of WT EndoIII and several mutants were examined for both
fully folded and thermally denatured protein (Figure 3A). All folded
samples exhibited similar spectral shapes.
In order to examine the stability of W178A and Y185A relative
toWTEndoIII, thermal denaturation experiments were performed.
In these experiments, the protein sample was heated gradually and
its ellipticity was measured as a function of temperature. The
ellipticity of all variants measured decreased with increasing tem-
perature, but W178A and Y185A denatured at a lower temperature
than WT EndoIII and a CT proficient mutant, Y82F (Figure 3B).
These data indicate thatW178A and Y185A are less stable thanWT
EndoIII.
Experimental Strategy Using AFM To Probe Protein Re-
distribution. We tested our model for protein redistribution
stimulated by DNA CT by preparing DNA strands containing a
single base mismatch, a modification that inhibits CT, and DNA
strands containing no mismatches. Our model would predict the
redistribution of proteins onto the mismatched strands. To
distinguish the strands by AFM, we made mismatched strands
>1000 base pairs longer than the matched strands. We employed
AFM to obtain a snapshot of repair proteins bound to DNA as
they search for damage (Figure 4).
Long (3.8 kb) DNA duplexes containing a site-specific CA
mismatch and short (2.2 and 1.6 kb) well-matched duplexes of
the same total sequence were therefore constructed. To prepare
these DNA samples, pUC19 plasmid was amplified with primers
Table 1. DNA Electrochemistry of EndoIII Mutantsa
EndoIII
midpoint potential
(mV vs NHE)b
mutant/WT ratio
(RR corrected)
WT 78
F30A 97 0.88 ( 0.03
Y55A 97 0.7 ( 0.1
Y75A 88 0.6 ( 0.2
L81C 84 1.1 ( 0.2
Y82C 92 0.8 ( 0.6
Y82F 91 1.2 ( 0.4
Y82S 91 0.4 ( 0.2
Y82W 92 1.4 ( 0.4
H140Ac 71 1.0 ( 0.2
W178A 83 3.5 ( 2.3
Y185A 85 2.2 ( 1.2
a Experimental conditions are described in Materials andMethods. Each
experiment used 50 μL of 50100 μM EndoIII in protein buffer
(20 mM NaH2PO4 pH 7.5, 100 mM NaCl, 5% glycerol, 1 mM EDTA).
bMeasurements have an uncertainty of (30 mV. cThis sample was not
measured using Redmond Red-modified DNA, although extra trials were
performed to verify the midpoint potential and signal strength ratio that
are shown.
Table 2. Summary of Glycosylase Assay Results with EndoIII
Mutantsa
EndoIII
% activity relative
to WT at 1 μM concn EndoIII
% activity relative to
WT at 1 μM concn
F30A 93.7 ( 2.6 Y82S 99.4 ( 1.6
Y55A 96.7 ( 1.0 Y82W 98.1 ( 3.6
Y75A 99.8 ( 4.0 H140A 39.1 ( 6.8
L81C 99.2 ( 0.6 W178A 98.2 ( 1.7
Y82C 99.2 ( 0.5 Y185A 97.3 ( 0.6
Y82F 99.4 ( 1.1
a Experimental conditions are described in Materials and Methods.
Experiments were conducted using 1 μM protein and 100 nM annealed
duplex in reaction buffer (10 mM Tris pH = 7.6, 1 mM EDTA, 50 mM
NaCl) for 15 min at 37 C. The reactions were quenched upon addition of
NaOH to a final concentration of 100 nM. Samples were dried, counted by
scintillation, and diluted with loading buffer (80% formamide, 10 mM
NaOH, 0.025% xylene cyanol, 0.025% bromophenol blue in Tris-Borate-
EDTA buffer) to normalize the radioactivity. Samples were then heated at
90 C for 5 min prior to loading and then separated by denaturing PAGE.
Glycosylase activity was determined by comparing the amount of 14-mer
produced to the total amount of DNA. The glycosylase activity of each
mutant as a percentage of WT is shown. Most mutants have activity within
error of that of WT.
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incorporating a 20-O-methyl residue to yield two short duplexes
containing 14-nucleotide single-strand overhangs. Upon ligation
of these two duplexes, 3.8 kbp strands contain only one CA
mismatch in the middle of the strand (Figure S2). The ligation
reaction was not taken to completion so as to have a mixture of
well-matched short and mismatched long strands for protein
distribution studies.
Although a CA mismatch effectively inhibits DNA CT,61 it is
not a lesion that is preferentially bound by EndoIII. Gel shift
assays on 21-mers with and without a central CA mismatch show
no detectable differences in EndoIII binding (data not shown).
Therefore, any differences in protein distribution can be attrib-
uted to nonspecific association.
We determined the proper biochemical conditions for protein/
DNA deposition by varying the volume of reaction mixture depo-
sited onto the mica surface (510 μL) and the concentration of
Mg2þ cation in the adsorption buffer (510 mM MgCl2). To
ensure that proteins were not attracted to the mica surface, DNA/
protein complexes were formed in solution 1 day prior to deposi-
tion. Some unbound proteins were observed on the mica surface
although the concentration of DNA (6 μM) was much higher than
that of the protein (0.40.6 μM) so as to reach binding
saturation. Protein assignments were verified through analysis
of their 35 nm heights in the images. In samples prepared
without protein, features of this dimension were not observed,
although some larger heights (>7 nm) were noted and attrib-
uted to salt precipitates. Only clearly identifiable long or short
strands and bound proteins were counted.
Atomic Force Microscopy of EndoIII Mutants. AFM images
of DNA-bound protein complexes are represented in Figure 4. As
observed, protein bound to DNA (Figure 4A,B) can be easily
distinguished based on strand height profiles of tapping mode
images (Figure 4C). Images of DNA with/without (Figure 4D)
protein were acquired with a scan size of 2 2 μm2 or 3 3 μm2
at a scan rate of 3.05 Hz. Since biomolecule surface density varied
between samples, >200 long and short strands were counted in at
least three independent trials. Error was calculated based on the
total number of proteins counted. Previously, we found that WT
EndoIII showed a significant preference for the longer strands
containing a CA mismatch.28 The ratio of protein binding
densities, r, for (long/short) was 1.6 with 5.6% error (total
proteins counted = 318). If instead we examined the distribution
of EndoIII on long versus short strands, where all strands were
matched, we saw a small preference for the short strands, with r
(long/short) = 0.9. On the basis of the DNA CT length and/or
the length of the DNA over which proteins can diffuse, we would
expect a ratio of 1 if there were an equal distribution of proteins
on matched and mismatched strands.
Note that these micrographs also provide a measure of relative
binding affinity of the mutants for DNA. All mutants examined in
these trials showed similar total amounts of proteins bound per
base pair, although variations were found in relative distributions
on the long and short strands.
In order to probe the CT role of aromatic residues at the
82 position, Y82F (0.6 μM) and DNA complexes were examined
with AFM. Y82F EndoIII, a mutant with CT activity comparable to
that of WT (Table 1), shows a redistribution onto long mismatched
strands with a binding density ratio, r (long/short) of 1.4 ( 0.09
(total proteins counted = 212), similar to that of WT protein. We
observed 0.15 proteins per kilobase of long strand and 0.10 proteins
per kilobase of short strand upon counting 260 long mismatched
strands and 346 shorter matched strands. Matched controls were
found from counting 250 long matched strands and 313 shorter
matched strands. We had earlier tested Y82A, which shows dimin-
ishedCTefficiency (50( 13%) relative toWTEndoIII.28 For Y82A,
r (long/short) is 0.9( 0.1, within error of wild type EndoIII bound
to fully matched long versus short strands. These results led us
to mutate other aromatic residues potentially involved in the DNA
protein CT pathway.
Y75A EndoIII mutant exhibits a signal that is 58 ( 20%
that of WT EndoIII (Table1). Significantly, similar to Y82A,
examination of the distribution of Y75A on mismatched and
matched strands by AFM shows no preference for the mis-
matched strand. Upon counting 303 long strands and 497 short
strands with 5% error, there is no preference for the mismatched
strands; Y75A exhibits a protein binding density ratio, r (long/
short) of 1.1 ( 0.05 (total proteins counted = 495) in mis-
matched samples, which is within error of fully matched (221
long strands and 296 short strands) density ratio r (long/short)
of 0.94( 0.06 for protein binding for fully matched strands (221
long strands and 296 short strands). Thus, this mutant that is also
deficient inDNACT also does not redistribute in our AFM assay.
Figure 3. Circular dichroism of EndoIII. (A) Comparison of fully
folded and denatured spectra of EndoIII. Samples were measured at
ambient temperature at a concentration of∼5 μM.WT spectra are shown,
although all mutants displayed a similar trend with denatured samples
(gray) consistently displaying less ellipticity than fully folded samples
(blue). The spectra shown are the average of three trials. (B) Circular
dichroism thermal denaturation of select EndoIII variants. Samples were
measured at concentrations of ∼5 μM. Each trace shown is the average
of at least three independent experiments. The graphs show the
fractional change in ellipticity for each variant measured, where the fully
folded protein was given a value of 0 and the denatured form was given a
value of 1, consistent with previous secondary structure studies.7 The
variants WT (dark blue) and Y82F (pale blue) display more structural
stability than W178A (orange) and Y185A (black).
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Though the [4Fe-4S] cluster is intact and the protein maintains
glycolytic activity, it cannot search for damage efficiently.
In order to probe residues near the [4Fe-4S] cluster, residues
W178 and Y185 were mutated to alanines. Both mutants
displayed DNA-bound electrochemical signals significantly
greater than that of WT EndoIII (Table 1). When W178A/
DNA complexes were studied by AFM, interestingly, they exhibit
a very high protein binding density ratio r (long/short) of 1.9(
0.09 (total proteins counted = 393). More strands were counted
in W178A samples than with other proteins: 303 long mis-
matched strands and 395 short matched strands. 499 long
matched strands and 505 short matched strands were counted
for controls with <5% error. We observed 0.25 proteins per
kilobase long strand and 0.14 proteins per kilobase short strand
in mismatched samples. There are∼2-fold more proteins bound
to the longer strands containing one single base mismatch in 3.8
kb compared to the well-matched strands. Upon performing
comparisons for the three individual samples from both long
matched and long mismatched strand images, all measurements
are within error of one another. W178A redistributes to an even
greater extent than WT EndoIII. This redistribution clearly
cannot be explained by binding specificity of EndoIII for the
mismatch. Note that all mutant/DNA complexes display heights
and strand lengths within error of WT EndoIII/DNA complexes
(Figure 5A). Figure 5B shows binding density ratio comparisons
for WT EndoIII and mutants: Y82A, Y75A, Y82F, and W178A.
These data indicate a strong correlation between the ability of
EndoIII to carry out DNA CT and its localization in the vicinity
of mismatches in AFM studies.
’DISCUSSION
Biochemical Characterization of EndoIII Mutants. Eleven
mutants of EndoIII were prepared and characterized biochemi-
cally in order to identify residues important for protein/DNA
CT. They were selected based on several criteria includ-
ing sequence conservation, aromatic character, and possible
association with cancer. Additionally, mutations were made in
several different regions of the protein to ascertain CT charac-
teristics of different domains (Figure 6). When assayed by cyclic
voltammetry on DNA-modified electrodes, all of the mutants
display midpoint potentials within error of that of WT EndoIII,
indicating an intact [4Fe-4S] cluster, irrespective of themutation.
Thus, our focus shifted to monitoring changes in signal intensity
Figure 4. Atomic force microscopy to visualize protein. Tapping mode AFM images of DNA and EndoIII protein onmica imaged in air. The mixture of
mismatched and matched strands (A) or fully matched long and short strands (B) and protein (dots) are visible on the surface. Images were acquired
with a scan size of 2 2 μm2 or 3 3 μm2, at a rate of 3.05Hz with a data scale of 10 nm/0.5 V. In (C) is shown a zoomed-in image of a DNA strand with
a bound protein subjected to height profiling to distinguish protein; the profile of the strand, to the right of the zoomed-in image, shows the height of
DNA ranges from 1 to 2 nm, with a much higher protein peak. In (D) is an AFM image taken of the DNA in the absence of protein.
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as a function of mutation, reflecting differences in coupling along
the path forDNA/proteinCT.The electrochemical studies coupled
with AFM experiments provide a measure of CT function: the
ability to redistribute repair proteins in the vicinity of a base lesion.
It is therefore remarkable to see the clear correlation between
electrochemical signal and the ability of the repair proteins to
redistribute in the vicinity of lesions (Figure 7). First this
correlation provides some confidence that electrochemical signal
strength on the DNA-modified electrodes is a useful measure of
Figure 5. EndoIII mutant binding density ratio comparisons. (A) Representative AFM images of DNA strands incubated overnight with Y82F EndoIII.
(B) Quantitation of protein density ratios (<10% uncertainty) where CA indicates a mismatch is contained in long strands. The unmarked bars show the
control measurements of for fully matched long and short strands. Y82A and Y75A, both CT deficient, do not show a redistribution onto themismatched
strand. Y82F and W178A, both CT proficient, redistribute similarly to WT.
Figure 6. Crystal structure of DNA-bound Endonuclease III. The struc-
ture shown was adapted from refs 10 and 14 and formatted using PyMol.75
Residues targeted for mutagenesis studies are emphasized in color.
Figure 7. Plot of protein binding density ratio versus electrochemical
signal. EndoIII mutants (Y82A (green), Y75A (purple),WT (red), Y82F
(blue), W178A (orange)) binding density ratios obtained for the
mixture of mismatched and matched strands are plotted against electro-
chemical signals. Mutants that are CT-deficient show low binding
density ratios and do not redistribute onto the mismatched strand,
while those with particularly high coupling to the DNA electrochemi-
cally (albeit with a high uncertainty in the measurement) show high
binding density ratios.
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protein/DNA coupling. But more importantly, this correlation
provides a direct link between DNA CT activity and lesion
detection and between protein/DNA coupling and function. We
can therefore consider various mutants we have prepared in the
context of protein/DNA CT.
Variations at the ProteinDNA Interface. L81 and Y82 are
both residues whose MUTYH equivalents exhibit mutations in
cancer patients,25 and Y82 is well conserved. Additionally, L81
and Y82 are extremely close to the DNA interface in bound
EndoIII. This proximity is important when the CT properties
of DNA are considered. DNA is able to mediate CT by means of
π-stacking, or the overlap of aromatic nucleotides, whose many
π-bonds provide an efficient conduit for electron flow.5,31,32,6266
L81 and Y82 may be able to intercalate into the DNA helix.9 L81
and Y82 would thus join the network of π-bonds in DNA that
facilitate electron flow. Consequently, L81 and Y82 were seen as
potentially important residues for mediating CT. Earlier research
from our laboratory confirmed this hypothesis by establishing
that Y82A is CT deficient relative toWT EndoIII.28 To follow up
on these experiments, additional mutants were made at L81 and
Y82 to assess, in more detail, the characteristics of CT-proficient
amino acids in EndoIII. L81C is CT proficient, so no definite
conclusions can be made about the electrochemical properties of
L81. The mutant Y82S is electrochemically deficient relative to
WT EndoIII, whereas Y82F and Y82W are CT proficient,
indicating that aromatic amino acids are important mediators
of CT at the Y82 position. This CT proficiency with an aromatic
residue at position 82 is reinforced by our AFM study where
Y82F shows an ability to relocalize onto the mismatched strand
that is comparable to WT.
It is interesting to consider mutations at these positions in the
context of colorectal cancer and DNA repair. EndoIII bears
structural similarity MUTYH. When MUTYH acquires certain
mutations, it is no longer able to repair damage in the adeno-
matous polyposis coli (APC) gene, which regulates the prolifera-
tion of colonic cells.25,67 APC is thought to be particularly
susceptible to MUTYH activity because it contains 216 “GAA”
codons in which a G:CfT:A transversion would result in a stop
codon. Genes associated with other cancers do not contain as
many such sites.25 Several MUTYH mutations have been de-
tected in colorectal cancer patients, including those at positions
Y114 and Y166.25 These residues align with F30 and Y82 in
EndoIII, respectively. Since certainmutations at Y82 are deficient
in CT activity but not enzymatic activity, perhaps the MUTYH
mutants are similarly deficient in CT. According to our BER
search model, these mutants would be less effective at detecting
DNA damage, allowing mutations to accumulate in the APC
gene that could lead to colorectal cancer.
Consideration of Pathways for DNA-Mediated CT. Crystal
structures of DNA-bound EndoIII place the [4Fe-4S] cluster and
DNA roughly 14 Å apart at their closest.10,12,14 At this distance,
CT could proceed by either a single-step tunneling process or a
multistep tunneling process, also called hopping, in which amino
acids act as “stepping stones” for the electron as it travels through
the protein.35,36,6870 In hopping systems, many of the amino
acids through which electrons hop are aromatic residues.36,68
With this information in mind, additional mutations were made
at aromatic residues closer to the interior of EndoIII to find
residues that could be part of a CT pathway. Emphasis was placed
on aromatic residues near Y82, as this tyrosine has already been
established as CT-active. F30, Y55, and Y75 all display weaker
electrochemical signals thanWTEndoIII, suggesting they participate
in a CT pathway. The distances covered are 9 Å from Y82 to Y75,
8 Å from Y75 to Y55, and 6 Å from Y55 to F30, which are
reasonable distances to consider in the context of hopping.35 It is
interesting to see the effects of mutations at Y75 both electro-
chemically and by AFM. Y75 is clearly biochemically active as a
glycosylase. However, functionally, both in carrying out DNA/
protein CT and in redistributing in the vicinity of a mismatch,
Y75 is defective. These results support the idea that Y75 is part
of a hopping pathway from the cluster to DNA interface. Time-
resolved spectroscopy will be necessary to distinguish these
pathways. Tunneling efficiency is exponential with distance,69
so even a slight reduction in tunneling distance can increase CT
rates significantly.
Beyond F30, the remainder of the CT pathway was not probed
for several reasons. First, many residues in the region between
F30 and the [4Fe-4S] cluster are part of the helixhairpinhelix
motif of EndoIII, a well-conserved motif in DNA-binding
proteins14,71 that helps these proteins interact with their sub-
strates. Mutations in this region could render the protein
unstable and/or unable to bind DNA. Second, mutations in this
region of the protein may not exhibit a detectable CT deficiency
even if the targeted residues are able to facilitate CT because
multiple CT pathways could be present, as is often the case in
redox-active proteins.70 In ribonucleotide reductase, for example,
electrons are known to find alternative pathways between two
redox centers if a primary pathway is impeded by mutagenesis or
incorporation of a non-natural amino acid.36,37 Similar phenom-
ena could occur in EndoIII, especially given that all of the
mutants examined display at least a partial signal, and that the
degree of attenuation lessens as the mutations are made further
from the DNA. The signal from Y82A is 50( 13% that of WT,28
whereas the signal from F30A is 88 ( 3% that of WT. These
values suggest that protein/DNA CT may involve Y82, but
that it could circumvent F30. Third, mutations very close to the
[4Fe-4S] cluster could compromise the stability of this cluster, as
may have been the case with the mutants W178A and Y185A.
Characterization of EndoIII Mutants with Large Electro-
chemical Signals. After establishing that mutations in aromatic
residues are more likely to impede CT in EndoIII, the mutants
W178A and Y185A were expected to produce weak cyclic
voltammetry signals. However, their CT activity is unexpectedly
high, larger even than that of WT EndoIII. It is more remarkable
still that AFM results support this higher coupling of the protein
with DNA for CT. This increase in protein/DNA coupling may
be attributed to structural changes near the [4Fe-4S] cluster of
the protein. The loss of the bulky, aromatic residues could
increase the conformational flexibility of EndoIII, allowing
water molecules to access the protein and accelerate CT to the
[4Fe-4S] cluster.72,73
One question that could be raised by this result is why alanine
is not present at positions 178 and 185 in the native protein since
it permits more efficient CT than tryptophan and tyrosine at
these positions. A possible answer to this question is presented by
the circular dichroism data. W178A and Y185A are found to be
less stable structurally than WT, and the resulting instability or
flexibility could affect the nearby [4Fe-4S] cluster. Aromatic
residues could play a protective role as well. Given the proximity
of W178 and Y185 to the [4Fe-4S] cluster of EndoIII, it is also
possible that these aromatic residues shield the cluster from
solvent exposure under physiological conditions. However, these
mutants still exhibit WT level enzymatic activity, indicating that
the structural perturbations are probably localized.
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DNA-Mediated Search for Damage within the Genome.
DNA CT provides a solution to the problem of how these BER
proteins can effectively scan the E. coli genome despite the low
copy number and poor specificity of the repair proteins. In fact,
CT through DNA with transfer over only a few hundred base
pairs is sufficient to decrease the genome scanning time signi-
ficantly.28 Here, AFM is utilized to probe this model of genome
scanning by following the redistribution of proteins near lesions.
It is interesting to note that in our AFM experiments only 14
proteins are bound to the long (3.8 kbp) strands, suggesting that
DNA CT is occurring over distances much greater (>500 bp)
than those we have measured electrochemically.4
Moreover, here, using mutagenesis, electrochemistry, and
AFM, we have probed possible electronic pathways between
DNA and the [4Fe-4S] cluster of the repair protein. Significantly,
Y82 has already been established as a cancer-relevant aromatic
residue located at the protein/DNA binding surface.28 Is Y82 the
moiety that captures electrons from the DNA: the protein’s “toe
in the water”? Mutation of W178, interestingly, results in both an
increase in DNA CT and efficient redistribution in AFM assays.
Likely here, as in other proteins, W178 serves to shield the
EndoIII [4Fe-4S] cluster, protecting the cluster from solvent and
reaction with water and oxygen.74 These results certainly support
the idea that mutations in repair proteins that alter DNA CT
influence the search for damage.
Importantly, the requirement for a rapid, comprehensive
search for damage is not a process limited to BER glycosylases.
DNA-binding proteins that contain [4Fe-4S] clusters with no
obvious functional role have been increasingly ubiquitous.31 The
results presented here elucidate a possible pathway through
which charge can travel between the DNA and the iron sulfur
cluster of EndoIII. Moreover, these results demonstrate that the
ability of the protein to performDNACT directly correlates with
its function as a first step in damage detection. Consequently,
these results add further support to the possibility that DNA-
bound proteins communicate in vivo bymeans of DNA-mediated
long-range signaling.
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